← Leaderboards
Alan Ross Morrison
Yale University
$5,386,740
Attributed
$5,483,452
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $908.8K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,483,452 · 5
VA$0 · 2
By mechanism
R01$4,024,323 · 2
P20$1,162,354 · 1
F32$167,826 · 1
T35$128,949 · 1
I01$0 · 1
IK2$0 · 1
Top collaborators
- Thomas Benedict Bartnikas2 shared
- Brittany Star Hampton2 shared
- Elizabeth O Harrington2 shared
Most similar at Yale University
Same institution · by research overlap
- Albert J Sinusas$22,904,679
- Kim Germaine Smolderen$1,112,640
- Hyung Joon Chun$6,877,171
- Chi Liu$11,811,709
- Mitchel R Stacy$5,154,894
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageInflammatorySignal TransductionPathway InteractionsBlood VesselsMorbidity - Disease RateMortalityChronicMolecularAtherosclerosisCellsSourceInflammationInterleukin-1 BetaCytokineLeadSignal PathwayPromoterLaboratoriesMediatingPlayApolipoprotein EIn VivoMedicine
Grant awards (32)
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged$513,781
R01 · FY2025 · HL · contact PI
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged$507,734
R01 · FY2024 · HL · contact PI
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged$67,877
R01 · FY2024 · HL · contact PI
Alpert Medical School Summer Research Program$51,932
T35 · FY2024 · HL
Reprogramming Macrophages to Improve Vascular Healing in Diabetes$0
I01 · FY2024 · VA · contact PI
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged$522,238
R01 · FY2023 · HL · contact PI
Alpert Medical School Summer Research Program$77,017
T35 · FY2023 · HL
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged$67,877
R01 · FY2023 · HL · contact PI
Reprogramming Macrophages to Improve Vascular Healing in Diabetes$0
I01 · FY2023 · VA · contact PI
Reprogramming Macrophages to Improve Vascular Healing in Diabetes$0
I01 · FY2023 · VA · contact PI
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged$537,039
R01 · FY2022 · HL · contact PI
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis$317,976
R01 · FY2022 · HL · contact PI
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged$49,190
R01 · FY2022 · HL · contact PI
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis$4,613
R01 · FY2022 · HL · contact PI
Reprogramming Macrophages to Improve Vascular Healing in Diabetes$0
I01 · FY2022 · VA · contact PI
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis$376,738
R01 · FY2021 · HL · contact PI
IL-1 Beta Signaling Promotes Atherosclerotic Calcification and Cardiovascular Risk$310,143
P20 · FY2021 · GM · contact PI
Reprogramming Macrophages to Improve Vascular Healing in Diabetes$0
I01 · FY2021 · VA · contact PI
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis$317,565
R01 · FY2020 · HL · contact PI
IL-1 Beta Signaling Promotes Atherosclerotic Calcification and Cardiovascular Risk$279,516
P20 · FY2020 · GM · contact PI
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis$54,357
R01 · FY2020 · HL · contact PI
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis$354,093
R01 · FY2019 · HL · contact PI
IL-1 Beta Signaling Promotes Atherosclerotic Calcification and Cardiovascular Risk$282,976
P20 · FY2019 · GM · contact PI
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis$323,024
R01 · FY2018 · HL · contact PI
IL-1 Beta Signaling Promotes Atherosclerotic Calcification and Cardiovascular Risk$289,719
P20 · FY2018 · GM · contact PI
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis$10,221
R01 · FY2018 · HL · contact PI
Calcific Atherosclerosis is Mediated by Macrophage Adhesion Signaling$0
IK2 · FY2017 · VA · contact PI
Calcific Atherosclerosis is Mediated by Macrophage Adhesion Signaling$0
IK2 · FY2016 · VA · contact PI
Calcific Atherosclerosis is Mediated by Macrophage Adhesion Signaling$0
IK2 · FY2015 · VA · contact PI
The Rac-2-induced macrophage proteome and vascular pathology$58,682
F32 · FY2011 · HL · contact PI
The Rac-2-induced macrophage proteome and vascular pathology$55,790
F32 · FY2010 · HL · contact PI
The Rac-2-induced macrophage proteome and vascular pathology$53,354
F32 · FY2009 · HL · contact PI